Innate Pharma SA Interest Paid Classified As Operating Activities
Innate Pharma SA (IPHYF) reported Interest Paid Classified As Operating Activities of EUR 400.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:InterestPaidClassifiedAsOperatingActivities · last filed 2026-04-01
| Period end | Interest Paid Classified As Operating Activities 6 month | Interest Paid Classified As Operating Activities 12 month | Interest Paid Classified As Operating Activities 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | 400.00K EUR 20-F · filed 2026-04-01 | ||
| 2025-06-30 | 200.00K EUR 6-K · filed 2025-09-17 | ||
| 2024-12-31 | 600.00K EUR 20-F · filed 2026-04-01 | 1.30M EUR 20-F · filed 2025-04-30 | |
| 2023-12-31 | 600.00K EUR 20-F · filed 2025-04-30 |